Moreover, down-regulation of PCAT-1 by interference RNA was enough to reduce cell proliferation in vitro, pointing to PCAT-1 as a potential therapeutic target of prostate cancer (Prensner et al., 2014). This evidence concerns the gene PCAT1 and Familial prostate cancer.